Prognostic indicators of primary sclerosing cholangitis determined by a cox phase-specific time-dependent model. od Boberg, K, Rocca, G, Spurkland, A, Broome, U, Chapman, R, Mitchell, S, Pares, A, Rosina, F, Schrumpf, E

HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups. od Saarinen, S, Boberg, K, Spurkland, A, Mitchell, S, Broome, U, Rosina, F, Chapman, R, Pares, A, Olerup, O, Schrumpf, E

Natural history of primary sclerosing cholangitis. A longterm follow-up study of 394 European primary sclerosing cholangitis patients od Boberg, K, Mitchell, S, Broome, U, Pares, A, Rosina, F, Bergquist, A, Chapman, R, Fause, O, Rocca, G, Schrumpf, E

Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patien... od Boberg, K, Bergquist, A, Mitchell, S, Pares, A, Rosina, F, Broome, U, Chapman, R, Fausa, O, Rocca, G, Schrumpf, E

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. od Boberg, K, Bergquist, A, Mitchell, S, Pares, A, Rosina, F, Broomé, U, Chapman, R, Fausa, O, Egeland, T, Rocca, G, Schrumpf, E

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. od Boberg, K, Spurkland, A, Rocca, G, Egeland, T, Saarinen, S, Mitchell, S, Broomé, U, Chapman, R, Olerup, O, Pares, A, Rosina, F, Schrumpf, E

New time dependent prognostic models for primary sclerosing cholangitis (PSC) od Rocca, G, Boberg, K, Egeland, T, Bergquist, A, Broome, U, Caballeria, L, Chapman, R, Hultcrantz, R, Mitchell, S, Pares, A, Rosina, F, Schrumpf, E

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis. od Boberg, K, Rocca, G, Egeland, T, Bergquist, A, Broomé, U, Caballeria, L, Chapman, R, Hultcrantz, R, Mitchell, S, Pares, A, Rosina, F, Schrumpf, E

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. od Spurkland, A, Saarinen, S, Boberg, K, Mitchell, S, Broome, U, Caballeria, L, Ciusani, E, Chapman, R, Ercilla, G, Fausa, O, Knutsen, I, Pares, A, Rosina, F, Olerup, O, Thorsby, E, Schrumpf, E

THE FIRST NEW MONOTHERAPY THERAPEUTIC PBC STUDY IN A DECADE? AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID IN PBC od Kowdley, K, Luketic, V, Jones, D, Chapman, R, Burroughs, A, Hirschfield, G, Poupon, R, Schramm, C, Vincent, C, Rust, C, Pares, A, Mason, A, Castelloe, E, Sciacca, C, Boehm, O, Pruzanski, M, Shapiro, D

AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID AS MONOTHERAPY IN PBC od Kowdley, K, Jones, D, Luketic, V, Chapman, R, Burroughs, A, Hirschfield, G, Poupon, R, Schramm, C, Vincent, C, Rust, C, Pares, A, Mason, A, Sciacca, C, Beecher-Jones, T, Bohm, O, Castelloe, E, Pruzanski, M, Shapiro, D, Grp, O

A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis od Kowdley, K, Luketic, V, Chapman, R, Hirschfield, G, Poupon, R, Schramm, C, Vincent, C, Rust, C, Parés, A, Mason, A, Marschall, H, Shapiro, D, Adorini, L, Sciacca, C, Beecher-Jones, T, Böhm, O, Pencek, R, Jones, D, Obeticholic Acid Pbc Monotherapy Study Group

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. od Liu, J, Hov, JR, Folseraas, T, Ellinghaus, E, Rushbrook, S, Doncheva, N, Andreassen, O, Weersma, R, Weismüller, T, Eksteen, B, Invernizzi, P, Hirschfield, G, Gotthardt, D, Pares, A, Ellinghaus, D, Shah, T, Juran, B, Milkiewicz, P, Rust, C, Schramm, C, Müller, T, Srivastava, B, Dalekos, G, Nöthen, M, Herms, S

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease od Ji, S-G, Juran, BD, Mucha, S, Folseraas, T, Jostins, L, Melum, E, Kumasaka, N, Atkinson, EJ, Schlicht, EM, Liu, JZ, Shah, T, Gutierrez-Achury, J, Boberg, KM, Bergquist, A, Vermeire, S, Eksteen, B, Durie, PR, Farkkila, M, Müller, T, Schramm, C, Sterneck, M, Weismüller, TJ, Gotthardt, DN, Ellinghaus, D, Braun, F, Teufel, A, Laudes, M, Lieb, W, Jacobs, G, Beuers, U, Weersma, RK, Wijmenga, C, Marschall, H-U, Milkiewicz, P, Pares, A, Kontula, K, Chazouillères, O, Invernizzi, P, Goode, E, Spiess, K, Moore, C, Sambrook, J, Ouwehand, WH, Roberts, DJ, Danesh, J, Floreani, A, Gulamhusein, AF, Eaton, JE, Schreiber, S, Chapman, RW, Et al.